Drug
Sulfadoxine clinical trials
- studies test it
- 12
- open now
- 2
- in phase 3
- 6
- first study started
- 2002
Keep track of what changes. Save the Sulfadoxine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
11 studies that test it; most in 2003 (3)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 6
- Phase 4
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 11
London School of Hygiene and Tropical Medicine (4) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · University of California, San Francisco (1) · Centers for Disease Control and Prevention (1) · Bernhard Nocht Institute for Tropical Medicine (1) · Tropical Medicine Research Institute (1) · Swiss Pharma Nigeria Limited (1) · Malaria Consortium (1)
Often tested with
Tested in the same studies.
Pyrimethamine (11) · Amodiaquine (4) · Artesunate (4) · Artemether (1) · Lumefantrine (1) · Chloroquine (1) · Chlorproguanil (1) · Dapsone (1)
Studies
Open first, then newest update. How each study uses Sulfadoxine is read from its arms, and is right about nine times in ten.
Testing it · 12
- Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible TabletNot yet recruitingPhase 1Swiss Pharma Nigeria LimitedNCT06522763Written as Sulfadoxine 500 MG / Pyrimethamine 25 MG dispersible tablets.
- Seasonal Malaria Chemoprevention Rapid Assessment Study MozambiqueNot yet recruitingPhase 4Malaria ConsortiumNCT06337253Written as Sulfadoxine/pyrimethamine plus amodiaquine
- Longitudinal Antimalarial Combinations in UgandaCompletedPhase 3University of California, San FranciscoNCT00123552Written as Amodiaquine+Sulfadoxine/Pyrimethamine
- SP Resistance and Falciparum Malaria TransmissionWithdrawnPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00299247Written as sulfadoxine/pyrimethamine
- Comparison of Two Strategies for the Delivery of IPTcCompletedPhase 4London School of Hygiene and Tropical MedicineNCT00376155Written as sulfadoxine /pyrimethamine plus amodiaquine
- IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.TerminatedPhase 3London School of Hygiene and Tropical MedicineNCT00361114Written as sulphadoxine/pyrimethamine
- Anti-Malarial Drug Resistance in CameroonCompletedPhase 2/3London School of Hygiene and Tropical MedicineNCT00146718Written as Amodiaquine and Sulphadoxine/Pyrimethamine
- A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese ChildrenCompletedPhase 2/3London School of Hygiene and Tropical MedicineNCT00132561Written as Sulfadoxine/pyrimethamine and artesunate
- Efficacy of Combination Therapy for Prevention of Effects of Malaria During PregnancyCompletedPhase 4Centers for Disease Control and PreventionNCT00164255Written as sulfadoxine/pyrimethamine
- CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in MalawiCompletedPhase 4National Institute of Allergy and Infectious Diseases (NIAID)NCT00125489Written as sulfadoxine/pyrimethamine
- Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in InfantsCompletedPhase 4Bernhard Nocht Institute for Tropical MedicineNCT00206739Written as Sulfadoxine (12.5 mg)/Pyrimethamine (250 mg)
- Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria TransmissionCompletedPhase 3Tropical Medicine Research InstituteNCT00646126Written as Sulfadoxine / Pyrimethamine (SP) plus artesunate (AS)
Given in every arm · 1 — Sulfadoxine is usual care beside what is tested
Codes
What other systems call Sulfadoxine · ClinicalTrials.gg INT008251
- MeSH (NLM) D013413SulfadoxineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 88463U4SM5SULFADOXINEConfirmed FDA, NLM, Wikidata
- RxNorm 10173Confirmed FDA, Wikidata
- Wikidata Q411557sulfadoxineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47735SulfadoxineOne source FDA
- DrugBank DB01299One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013413 | Sulfadoxine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 88463U4SM5 | SULFADOXINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10173 | — | Confirmed FDA, Wikidata |
| Wikidata | Q411557 | sulfadoxine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47735 | Sulfadoxine | One source FDA |
| DrugBank | DB01299 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.